Neutrophil CD64 expression as a longitudinal biomarker for severe disease and acute infection in critically ill patients.

This study demonstrated that CD64 discriminates between critically ill patients with culture positive and negative sepsis and correlates with severity of disease. However, CD64 index is not a good predictor for 28-day mortality in the critically ill patient.